History and Science Music Vids – Egypt

I really do love what historyteachers have done, combining pop music, fun videos on youTube, and educational information on historical and scientific topics. This is an awesome way to teach and get involvement from students. Besides these are just simply awesome.

Today’s topic:  Historical Egypt

 

Usual Disclaimer:  As usual, I did not make these I just found them.

First transfusions of “manufactured” blood planned for 2016

wildcat2030:

See on Scoop.itThe future of medicine and health
image

According to the World Health Organization, approximately 107 million blood donations are collected globally every year. Nonetheless, blood is often in short supply – particularly in developing nations. Despite new safeguards, there’s…

First transfusions of “manufactured” blood planned for 2016

Quote, Neil deGrasse Tyson, The scientific fact of Global Warming

Is it political if I tell you that if we burn coal, you’re going to warm the atmosphere? Or is that a statement of fact that you’ve made political? It’s a scientific statement. The fact that there are elements of society that have made it political, that’s a whole other thing.

Neil deGrasse Tyson (via socio-logic)

Manufactured Blood – from The Telegraph

s-c-i-guy:

Artificial blood ‘will be manufactured in factories’

It is the stuff of gothic science fiction: men in white coats in factories of blood and bones.

But the production of blood on an industrial scale could become a reality once a trial is conducted in which artificial blood made from human stem cells is tested in patients for the first time.

It is the latest breakthrough in scientists’ efforts to re-engineer the body, which have already resulted in the likes of 3d-printed bones and bionic limbs.

Marc Turner, the principal researcher in the £5 million programme funded by the Wellcome Trust, told The Telegraph that his team had made red blood cells fit for clinical transfusion.

Prof Turner has devised a technique to culture red blood cells from induced pluripotent stem (iPS) cells – cells that have been taken from humans and ‘rewound’ into stem cells. Biochemical conditions similar to those in the human body are then recreated to induce the iPS cells to mature into red blood cells – of the rare universal blood type O.

“Although similar research has been conducted elsewhere, this is the first time anybody has manufactured blood to the appropriate quality and safety standards for transfusion into a human being,” said Prof Turner.

There are plans in place for the trial to be concluded by late 2016 or early 2017, he said. It will most likely involve the treatment of three patients with Thalassaemia, a blood disorder requiring regular transfusions. The behaviour of the manufactured blood cells will then be monitored.

“The cells will be safe,” he said, adding that there are processes whereby cells can be removed.

The technique highlights the prospect of a limitless supply of manufactured type-O blood, free of disease and compatible with all patients.

“Although blood banks are well-stocked in the UK and transfusion has been largely safe since the Hepatitis B and HIV infections of the 1970s and 1980s, many parts of the world still have problems with transfusing blood,” said Prof Turner.

However, scaling up the process to meet demand will be a challenge, as Prof Turner’s laboratory conditions are not replicable on an industrial scale. “A single unit of blood contains a trillion red blood cells. There are 2 million units of blood transfused in the UK each year,” he said.

Currently, it costs approximately £120 to transfuse a single unit of blood. If Prof Turner’s technique is scaled up efficiently, it could substantially reduce costs.

Dr Ted Bianco, Director of Technology Transfer at the Wellcome Trust, said: “One should not underestimate the challenge of translating the science into routine procedures for the clinic. Nowhere is this more apparent than in the challenge Professor Turner and colleagues have set out to address, which is to replace the human blood donor as the source of supply for life-saving transfusions.”

For the moment, factories of blood remain the stuff of fiction.

source